MarketResearchReport2021

  Daptomycin Market 2022 Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces rose sports. Daptomycin is used for the treatment of various bacterial infections caused by gram-positive bacteria. The growth of the global Daptomycin Market can be attributed to the high demand of daptomycin due to rising infections in the bloodstream, and increasing complicated skin and skin structure infections. According to MRFR analysis, the Global  Daptomycin Market   is expected to register a  CAGR of 4.4%  during the forecast period 2020 to 2027 and reach  USD 5,122.7 Million by 2027. Furthermore, the rise of right-sided infective endocarditis, and daptomycin as an antibacterial drug, a bacterial metabolite and a member of calcium-dependent antibiotics, are also expected to fuel the market growth during the forecast period. However, increasing rates of infection with gram-positive bacteria and the rapid emergence of resistance to the n...

  Daptomycin Market 2021 According to MRFR analysis, the Global  Daptomycin Market   is expected to register a  CAGR of 4.4%  during the forecast period 2020 to 2027 and reach  USD 5,122.7 Million by 2027. Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces rose sports. Daptomycin is used for the treatment of various bacterial infections caused by gram-positive bacteria. The growth of the global Daptomycin Market can be attributed to the high demand of daptomycin due to rising infections in the bloodstream, and increasing complicated skin and skin structure infections. Furthermore, the rise of right-sided infective endocarditis, and daptomycin as an antibacterial drug, a bacterial metabolite and a member of calcium-dependent antibiotics, are also expected to fuel the market growth during the forecast period. However, increasing rates of infection with gram-positive bacteria and the rapid emergence of resistance to the n...